13 AUGUST 2026
Healthcare stocks have performed well of late, buoyed by solid earnings, encouraging regulatory news and major research breakthroughs.
An extraordinary sequence of clinical milestones prompted many from the scientific community to label May a “miracle month” for medical innovation.
The multi-year underperformance of healthcare stocks has depressed the sector’s weight in major equity indices.
And as the chart below shows, healthcare valuations relative to the general stock market have fallen to multi-year lows.
But with general corporate earnings now facing tough year-on-year comparisons, the strong revenue momentum of healthcare stocks should stand out.
Which suggests this nascent sector rotation into healthcare may have further to run.
Bentley Reid & Co (UK) Limited (FRN 572096) is authorised and regulated by the Financial Conduct Authority.
This communication is provided for information purposes only. Bentley Reid believes that, at the time of publication, the views expressed herein represent fair opinion; however, no assurance can be given that any illustrated or referenced performance will be achieved or repeated. All data and graphical information are believed to be accurate at the time of capture but may be subject to change and may not reflect current conditions. Fluctuations in exchange rates may cause the value of investments to rise or fall.
Recipients considering any action based on the content of this communication should seek independent advice from a professional adviser appropriate to their individual financial circumstances. Capital is at risk, and investors may receive back less than the amount originally invested. Neither the publisher nor any of its subsidiaries or connected parties accepts any liability for direct or indirect loss arising from reliance on, or use of, the information contained in this communication.
With US debt nearing US$40 trillion, investors are questioning how long higher borrowing costs can…
Inflation concerns are rising again, but well-anchored expectations suggest persistent inflation pressures remain limited.
How strong nominal growth, rising bond yields and slowing economic indicators are shaping the investment…
